H
-
Hodgkin Lymphoma
Does FDG PET/CT have Additional Diagnostic Accuracy of Surveillance in Detection of Early Relapse in Non- Hodgkin Lymphoma? [Volume 20, Issue 1, 2020, Pages 18-38]
I
-
Internal dosimetry
Assessment of Organ Doses for Patients undergoing 99mTc-MIBI Myocardial Perfusion Imaging. [Volume 20, Issue 1, 2020, Pages 82-93]
M
-
Malignant Lymphoma & PET/CT & Pitfalls
How Hybrid PET/CT Improve Pitfalls and Artifacts in Malignant Lymphoma? [Volume 20, Issue 1, 2020, Pages 64-81]
-
MIRDOSE
Assessment of Organ Doses for Patients undergoing 99mTc-MIBI Myocardial Perfusion Imaging. [Volume 20, Issue 1, 2020, Pages 82-93]
-
Myocardial Perfusion Imaging
Assessment of Organ Doses for Patients undergoing 99mTc-MIBI Myocardial Perfusion Imaging. [Volume 20, Issue 1, 2020, Pages 82-93]
O
-
OLINDA
Assessment of Organ Doses for Patients undergoing 99mTc-MIBI Myocardial Perfusion Imaging. [Volume 20, Issue 1, 2020, Pages 82-93]
P
-
PET/CT Surveillance & Early Relapse & Non
Does FDG PET/CT have Additional Diagnostic Accuracy of Surveillance in Detection of Early Relapse in Non- Hodgkin Lymphoma? [Volume 20, Issue 1, 2020, Pages 18-38]
S
-
SPECT
Assessment of Organ Doses for Patients undergoing 99mTc-MIBI Myocardial Perfusion Imaging. [Volume 20, Issue 1, 2020, Pages 82-93]
Your query does not match with any item